Tanaproget is a potent, orally bioavailable, non-steroidal progesterone receptor agonist (IC50 = 1.7 nM for hPR). Its pharmacological profile, including induction of alkaline phosphatase and suppression of endometrial MMPs, supports its use in research models for female reproductive health, such as contraception and endometriosis.